+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Whole Exome Sequencing Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables, Services), Technology, Workflow, Application, End-use, Region, and Segment Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • October 2024
  • Region: Global
  • Grand View Research
  • ID: 5830858
The global whole exome sequencing market size is expected to reach USD 1.27 billion by 2030, registering to grow at a CAGR of 18.44% from 2024 to 2030 . One of the primary factors driving the market is the advancement in technology for whole exome sequencing. High throughput technology is becoming more widely used in clinical diagnostics and research which helps doctors to better understand the exome sequence disorders and made a treatment accordingly. Additionally, the rising prevalence of genetic conditions has enabled the adoption of whole exome sequencing for the investigation of protein coding regions and the derivation of valuable output about genetic variants.

Additionally, the significant increase in research including whole exomes is driven by the availability of data analysis and interpretation software. The use of these tools and software to examine genetic data is easy and it provides a fresh insight into the underlying causes of genetic abnormalities and diseases. For instance, in May 2022, Illumina’s subsidiary Grail, announced a partnership with the U.S. Department of Veterans Affairs, to provide their Galleri multi-cancer early detection test to U.S. veterans. This test utilizes whole exome sequences to detect multiple types of cancer in the early stages. This partnership exemplifies how the usage of whole exome sequencing and advanced data analysis tools can enable large-scale genomic research and transform the future of precision medicine.

The market has been significantly impacted by the COVID-19 pandemic. An example of how whole exomes have been used to better understand the virus and its dissemination is the COVID-19 Genomics UK Consortium study. The pandemic has also brought attention to the promise of exome sequence in the fight against infectious diseases, spurring additional investment in this field of study. The entire market is anticipated to develop in the upcoming years despite difficulties brought on by the pandemic in 2020.

Whole Exome Sequencing Market Report Highlights

  • The consumables segment dominated the market in 2024 with a market share of 62.36%. This is due to whole exome sequencing’s requirement of a variety of consumable items, including reagents, kits, and sample preparation consumables, which are essential for conducting whole exome sequencing investigations.
  • Sequencing by synthesis segment dominated the market in 2024 with a market share of 73.49%. This is due to the effectiveness and affordability of the sequencing by synthesis approach that has increased its appeal.
  • The sequencing segment had a dominating presence in the market in 2024 with a market share of 49.90%, due to the growing demand for genetic testing services and personalized medicine. Whole exome sequencing has the ability to analyze large number of genetic data in a less cost, additionally it allows for more comprehensive analysis of genetic variation.
  • Drug discovery & development segment dominated the market in 2024 with a market share of 47.38% due to it plays a crucial part in advancing the development of new drugs. Whole exome sequencing has become a compelling method for locating gene variations and disease-causing mutations that can be exploited to create tailored treatments.
  • The academic & research institutes segment in whole exome sequencing market dominated the market in 2024, with a share of 47.32%. The dominance of the segment is due to the increasing demand for personalized medicines and healthcare.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
  • Competitive Landscape: Explore the market presence of key players worldwide
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

The leading players in the Whole Exome Sequencing market include:

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc
  • Agilent Technologies, Inc
  • BGI
  • PacBio
  • Oxford Nanopore Technologies plc.
  • Azenta US Inc. (GENEWIZ)
  • CD Genomics
  • Novogene Co Ltd
  • Eurofins Genomics


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product Segment
1.1.1.2. Technology Segment
1.1.1.3. Workflow Segment
1.1.1.4. Application Segment
1.1.1.5. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations
1.11. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing Prevalence of Genetic Diseases
3.2.1.2. Technological Advancements in Sequencing Platforms and Data Analysis Tools
3.2.1.3. Decreasing Costs of Sequencing
3.2.2. Market Restraint Analysis
3.2.2.1. High Complexity and Costs Associated with Data Storage, Interpretation & Analysis
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Segment Dashboard
4.2. Whole Exome Sequencing Market: Product Movement Analysis
4.3. Whole Exome Sequencing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Instruments
4.4.1. Instruments Market, 2018 - 2030 (USD Million)
4.5. Consumables
4.5.1. Consumables Market, 2018 - 2030 (USD Million)
4.6. Services
4.6.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. Technology Business Analysis
5.1. Segment Dashboard
5.2. Whole Exome Sequencing Market: Technology Movement Analysis
5.3. Whole Exome Sequencing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. Sequencing by Synthesis
5.4.1. Sequencing By Synthesis Market, 2018 - 2030 (USD Million)
5.5. ION Semiconductor Sequencing
5.5.1. ION Semiconductor Sequencing Market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Other Technology Market, 2018 - 2030 (USD Million)
Chapter 6. Workflow Business Analysis
6.1. Segment Dashboard
6.2. Whole Exome Sequencing Market: Workflow Movement Analysis
6.3. Whole Exome Sequencing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
6.4. Pre-Sequencing
6.4.1. Pre-Sequencing Market, 2018 - 2030 (USD Million)
6.5. Sequencing
6.5.1. Sequencing Market, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Other Workflow Market, 2018 - 2030 (USD Million)
Chapter 7. Application Business Analysis
7.1. Segment Dashboard
7.2. Whole Exome Sequencing Market: Application Movement Analysis
7.3. Whole Exome Sequencing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
7.4. Clinical Diagnostics
7.4.1. Clinical Diagnostics Market, 2018 - 2030 (USD Million)
7.5. Drug Discovery & Development
7.5.1. Drug Discovery & Development Market, 2018 - 2030 (USD Million)
7.6. Personalized Medicines
7.6.1. Personalized Medicines Market, 2018 - 2030 (USD Million)
7.7. Others
7.7.1. Other Application Market, 2018 - 2030 (USD Million)
Chapter 8. End Use Business Analysis
8.1. Segment Dashboard
8.2. Whole Exome Sequencing Market: End Use Movement Analysis
8.3. Whole Exome Sequencing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Academic And Research Institutes
8.4.1. Academic And Research Institutes Market, 2018 - 2030 (USD Million)
8.5. Hospitals & Clinics
8.5.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
8.6. Pharmaceutical & Biotechnology Companies
8.6.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
8.7. Others
8.7.1. Other End use Market, 2018 - 2030 (USD Million)
Chapter 9. Regional Business Analysis
9.1. Regional Market Share Analysis, 2024 & 2030
9.2. Regional Market Dashboard
9.3. North America
9.3.1. North America Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.3.2. U.S.
9.3.2.1. Key Country Dynamics
9.3.2.2. Target Disease Prevalence
9.3.2.3. Competitive Scenario
9.3.2.4. Regulatory Framework
9.3.2.5. U.S. Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.3.3. Canada
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Competitive Scenario
9.3.3.4. Regulatory Framework
9.3.3.5. Canada Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.3.4. Mexico
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Competitive Scenario
9.3.4.4. Regulatory Framework
9.3.4.5. Mexico Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4. Europe
9.4.1. Europe Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4.2. UK
9.4.2.1. Key Country Dynamics
9.4.2.2. Target Disease Prevalence
9.4.2.3. Competitive Scenario
9.4.2.4. Regulatory Framework
9.4.2.5. UK Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4.3. Germany
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Competitive Scenario
9.4.3.4. Regulatory Framework
9.4.3.5. Germany Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4.4. France
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Competitive Scenario
9.4.4.4. Regulatory Framework
9.4.4.5. France Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4.5. Italy
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Competitive Scenario
9.4.5.4. Regulatory Framework
9.4.5.5. Italy Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4.6. Spain
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Competitive Scenario
9.4.6.4. Regulatory Framework
9.4.6.5. Spain Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4.7. Denmark
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Competitive Scenario
9.4.7.4. Regulatory Framework
9.4.7.5. Denmark Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4.8. Sweden
9.4.8.1. Key Country Dynamics
9.4.8.2. Target Disease Prevalence
9.4.8.3. Competitive Scenario
9.4.8.4. Regulatory Framework
9.4.8.5. Sweden Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.4.9. Norway
9.4.9.1. Key Country Dynamics
9.4.9.2. Target Disease Prevalence
9.4.9.3. Competitive Scenario
9.4.9.4. Regulatory Framework
9.4.9.5. Norway Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.5. Asia Pacific
9.5.1. Asia Pacific Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.5.2. Japan
9.5.2.1. Key Country Dynamics
9.5.2.2. Target Disease Prevalence
9.5.2.3. Competitive Scenario
9.5.2.4. Regulatory Framework
9.5.2.5. Japan Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.5.3. China
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Competitive Scenario
9.5.3.4. Regulatory Framework
9.5.3.5. China Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.5.4. India
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Prevalence
9.5.4.3. Competitive Scenario
9.5.4.4. Regulatory Framework
9.5.4.5. India Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.5.5. Australia
9.5.5.1. Key Country Dynamics
9.5.5.2. Target Disease Prevalence
9.5.5.3. Competitive Scenario
9.5.5.4. Regulatory Framework
9.5.5.5. Australia Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.5.6. Thailand
9.5.6.1. Key Country Dynamics
9.5.6.2. Target Disease Prevalence
9.5.6.3. Competitive Scenario
9.5.6.4. Regulatory Framework
9.5.6.5. Thailand Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.5.7. South Korea
9.5.7.1. Key Country Dynamics
9.5.7.2. Target Disease Prevalence
9.5.7.3. Competitive Scenario
9.5.7.4. Regulatory Framework
9.5.7.5. South Korea Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.6. Latin America
9.6.1. Latin America Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.6.2. Brazil
9.6.2.1. Key Country Dynamics
9.6.2.2. Target Disease Prevalence
9.6.2.3. Competitive Scenario
9.6.2.4. Regulatory Framework
9.6.2.5. Brazil Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.6.3. Argentina
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Competitive Scenario
9.6.3.4. Regulatory Framework
9.6.3.5. Argentina Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.7. MEA
9.7.1. MEA Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.7.2. South Africa
9.7.2.1. Key Country Dynamics
9.7.2.2. Target Disease Prevalence
9.7.2.3. Competitive Scenario
9.7.2.4. Regulatory Framework
9.7.2.5. South Africa Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.7.3. Saudi Arabia
9.7.3.1. Key Country Dynamics
9.7.3.2. Target Disease Prevalence
9.7.3.3. Competitive Scenario
9.7.3.4. Regulatory Framework
9.7.3.5. Saudi Arabia Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.7.4. UAE
9.7.4.1. Key Country Dynamics
9.7.4.2. Target Disease Prevalence
9.7.4.3. Competitive Scenario
9.7.4.4. Regulatory Framework
9.7.4.5. UAE Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
9.7.5. Kuwait
9.7.5.1. Key Country Dynamics
9.7.5.2. Target Disease Prevalence
9.7.5.3. Competitive Scenario
9.7.5.4. Regulatory Framework
9.7.5.5. Kuwait Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Market Share Analysis, 2024
10.4. Company Profiles/Listing
10.4.1. Thermo Fisher Scientific, Inc.
10.4.1.1. Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Illumina, Inc.
10.4.2.1. Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Agilent Technologies, Inc
10.4.3.1. Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Strategic Initiatives
10.4.4. BGI
10.4.4.1. Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Strategic Initiatives
10.4.5. PacBio
10.4.5.1. Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Strategic Initiatives
10.4.6. Oxford Nanopore Technologies plc.
10.4.6.1. Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Strategic Initiatives
10.4.7. Azenta US Inc. (GENEWIZ)
10.4.7.1. Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Strategic Initiatives
10.4.8. CD Genomics
10.4.8.1. Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Strategic Initiatives
10.4.9. Novogene Co, Ltd
10.4.9.1. Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Strategic Initiatives
10.4.10. Eurofins Genomics
10.4.10.1. Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Strategic Initiatives
List of Table
Table 1 List of abbreviations
Table 2 Global whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 3 Global whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 4 Global whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 5 Global whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 6 Global whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 7 Global whole exome sequencing market, by region, 2018 - 2030 (USD Million)
Table 8 North America whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 9 North America whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 10 North America Whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 11 North America Whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 12 North America Whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 13 North America whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 14 U.S. whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 15 U.S. whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 16 U.S. whole Exome Sequencing Market, by workflow, 2018 - 2030 (USD Million)
Table 17 U.S. whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 18 U.S. whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 19 Canada whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 20 Canada whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 21 Canada whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 22 Canada whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 23 Canada whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 24 Mexico whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 25 Mexico whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 26 Mexico whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 27 Mexico whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 28 Mexico whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 29 Europe whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 30 Europe whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 31 Europe whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 32 Europe whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 33 Europe whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 34 Europe whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 35 UK whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 36 UK whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 37 UK whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 38 UK whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 39 UK whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 40 Germany whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 41 Germany whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 42 Germany whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 43 Germany whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 44 Germany whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 45 France whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 46 France whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 47 France whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 48 France whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 49 France whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 50 Italy whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 51 Italy whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 52 Italy whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 53 Italy whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 54 Italy whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 55 Spain whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 56 Spain whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 57 Spain whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 58 Spain whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 59 Spain whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 60 Denmark whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 61 Denmark whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 62 Denmark whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 63 Denmark whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 64 Denmark whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 65 Sweden whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 66 Sweden whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 67 Sweden whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 68 Sweden whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 69 Sweden whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 70 Norway whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 71 Norway whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 72 Norway whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 73 Norway whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 74 Norway whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 75 Asia Pacific whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 76 Asia Pacific whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 77 Asia Pacific whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 78 Asia Pacific whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 79 Asia Pacific whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 80 Asia Pacific whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 81 Japan whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 82 Japan whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 83 Japan whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 84 Japan whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 85 Japan whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 86 China whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 87 China whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 88 China whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 89 China whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 90 China whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 91 India whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 92 India whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 93 India whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 94 India whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 95 India whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 96 Australia whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 97 Australia whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 98 Australia whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 99 Australia whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 100 Australia whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 101 Thailand whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 102 Thailand whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 103 Thailand whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 104 Thailand whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 105 Thailand whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 106 South Korea whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 107 South Korea whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 108 South Korea whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 109 South Korea whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 110 South Korea whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 111 Latin America whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 112 Latin America whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 113 Latin America whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 114 Latin America whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 115 Latin America whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 116 Latin America whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 117 Brazil whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 118 Brazil whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 119 Brazil whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 120 Brazil whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 121 Brazil whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 122 Argentina whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 123 Argentina whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 124 Argentina whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 125 Argentina whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 126 Argentina whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 127 Middle East & Africa whole exome sequencing market, by country, 2018 - 2030 (USD Million)
Table 128 Middle East & Africa whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 129 Middle East & Africa whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 130 Middle East & Africa whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 131 Middle East & Africa whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 132 Middle East & Africa whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 133 South Africa whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 134 South Africa whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 135 South Africa whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 136 South Africa whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 137 South Africa whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 143 UAE whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 144 UAE whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 145 UAE whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 146 UAE whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 147 UAE whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
Table 148 Kuwait whole exome sequencing market, by product, 2018 - 2030 (USD Million)
Table 149 Kuwait whole exome sequencing market, by technology, 2018 - 2030 (USD Million)
Table 150 Kuwait whole exome sequencing market, by workflow, 2018 - 2030 (USD Million)
Table 151 Kuwait whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 152 Kuwait whole exome sequencing market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Global whole exome sequencing market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Parent market outlook
Fig. 11 Global whole exome sequencing market driver analysis
Fig. 12 Global whole exome sequencing market restraint analysis
Fig. 13 Global whole exome sequencing market: Porter's analysis
Fig. 14 Global whole exome sequencing market: PESTEL analysis
Fig. 15 Global whole exome sequencing market: Product movement analysis
Fig. 16 Global whole exome sequencing market, for instruments, 2018 - 2030 (USD Million)
Fig. 17 Global whole exome sequencing market, for consumables, 2018 - 2030 (USD Million)
Fig. 18 Global whole exome sequencing market, for services, 2018 - 2030 (USD Million)
Fig. 19 Global whole exome sequencing market: Technology movement analysis
Fig. 20 Global whole exome sequencing market, for sequencing by synthesis, 2018 - 2030 (USD Million)
Fig. 21 Global whole exome sequencing market, for ION semiconductor sequencing, 2018 - 2030 (USD Million)
Fig. 22 Global whole exome sequencing market, for other technology, 2018 - 2030 (USD Million)
Fig. 23 Global whole exome sequencing market: Workflow movement analysis
Fig. 24 Global whole exome sequencing market, for pre-sequencing, 2018 - 2030 (USD Million)
Fig. 25 Global whole exome sequencing market, for sequencing, 2018 - 2030 (USD Million)
Fig. 26 Global whole exome sequencing market, for data analysis, 2018 - 2030 (USD Million)
Fig. 27 Global whole exome sequencing market: Application movement analysis
Fig. 28 Global whole exome sequencing market, for clinical diagnostics, 2018 - 2030 (USD Million)
Fig. 29 Global whole exome sequencing market, for drug discovery & development, 2018 - 2030 (USD Million)
Fig. 30 Global whole exome sequencing market, for personalized medicine, 2018 - 2030 (USD Million)
Fig. 31 Global whole exome sequencing market, for other applications, 2018 - 2030 (USD Million)
Fig. 32 Global whole exome sequencing market: End use movement analysis
Fig. 33 Global whole exome sequencing market, for academic & research institutes, 2018 - 2030 (USD Million)
Fig. 34 Global whole exome sequencing market, for hospitals & clinics, 2018 - 2030 (USD Million)
Fig. 35 Global whole exome sequencing market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
Fig. 36 Global whole exome sequencing market, for other end use, 2018 - 2030 (USD Million)
Fig. 37 Regional marketplace: Key takeaways
Fig. 38 Regional outlook, 2024 & 2030
Fig. 39 Global whole exome sequencing market: Region movement analysis
Fig. 40 North America whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 41 U.S. whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 42 Canada whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 43 Mexico whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 44 Europe whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 45 Germany whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 46 UK whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 47 France whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 48 Italy whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 49 Spain whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 50 Denmark whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 51 Sweden whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 52 Norway whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 54 Japan whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 55 China whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 56 India whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 57 Australia whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 58 South Korea whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 59 Thailand whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 60 Latin America whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 61 Brazil whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 62 Argentina whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 63 Middle East and Africa whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 64 South Africa whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 65 Saudi Arabia whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 66 UAE whole exome sequencing market, 2018 - 2030 (USD Million)
Fig. 67 Kuwait whole exome sequencing market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc
  • Agilent Technologies, Inc
  • BGI
  • PacBio
  • Oxford Nanopore Technologies plc.
  • Azenta US Inc. (GENEWIZ)
  • CD Genomics
  • Novogene Co Ltd
  • Eurofins Genomics

Methodology

Loading
LOADING...